R.I. Lopez
Impact in
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
-
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 3
-
- Advances in Oncology and Radiotherapy 1
- Monoclonal and Polyclonal Antibodies Research 1
- Co-authors
- Neelima Denduluri (1 shared paper)Cheng S. Quah (2 shared papers)Carlos Bais (2 shared papers)Jean‐Luc Canon (1 shared paper)Yaroslav Shparyk (1 shared paper)Norikazu Masuda (1 shared paper)Igor Bondarenko (2 shared papers)Seock‐Ah Im (1 shared paper)
- Journals
- European Journal of Cancer (2 papers)Journal of Thoracic Oncology (1 paper)Clinical Oncology (1 paper)Value in Health (1 paper)ESMO Open (1 paper)
- Partner nations
- SwitzerlandHungarySouth Korea
In The Last Decade
R.I. Lopez
7 papers receiving 170 citations
Peers
Comparison fields: 5 of 38
- Oncology 95
- Cancer Research 31
- Ecology, Evolution, Behavior and Systematics 26
- Hepatology 6
- Complementary and alternative medicine 6
Countries citing papers authored by R.I. Lopez
This map shows the geographic impact of R.I. Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.I. Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.I. Lopez more than expected).
Fields of papers citing papers by R.I. Lopez
This network shows the impact of papers produced by R.I. Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.I. Lopez. The network helps show where R.I. Lopez may publish in the future.
Co-authors
The 25 scholars most cited alongside R.I. Lopez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 97 | |
| 2 | [A zinc sulfate and usnic acid preparation used as post-surgical adjuvant therapy in genital lesions by Human Papillomavirus]. | 1999 | 31 |
| 3 | 2013 | 24 | |
| 4 | 2018 | 10 | |
| 5 | 2015 | 7 | |
| 6 | 2012 | 5 | |
| 7 | 2014 | 1 | |
| 8 | 2016 | 0 | |
| 9 | 2018 | 0 |
About R.I. Lopez
R.I. Lopez is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Ecology, Evolution, Behavior and Systematics, having authored 9 papers that have together received 175 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (3 papers), Advances in Oncology and Radiotherapy (1 paper), Lichen and fungal ecology (1 paper), Global Health and Surgery (1 paper), School Health and Nursing Education (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Smoking Behavior and Cessation (1 paper). The work is most often cited by research in Oncology (95 citations), Cancer Research (31 citations), Ecology, Evolution, Behavior and Systematics (26 citations), Hepatology (6 citations) and Complementary and alternative medicine (6 citations). R.I. Lopez has collaborated with scholars based in Switzerland, Hungary and South Korea. Frequent co-authors include Neelima Denduluri, Cheng S. Quah, Carlos Bais, Jean‐Luc Canon, Yaroslav Shparyk, Norikazu Masuda, Igor Bondarenko, Seock‐Ah Im, Stanislas Hubeaux and David Miles. Their work appears in journals such as European Journal of Cancer, Journal of Thoracic Oncology, Clinical Oncology, Value in Health and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.